alanine has been researched along with Gastritis in 21 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| " pylori-infected chronic gastritis by preventing the production of inflammatory cytokines and chemokines, as does cimetidine, but may be preferable to cimetidine for long-term administration for treatment of H." | 7.72 | Comparison of the effects of rebamipide with those of cimetidine on chronic gastritis associated with Helicobacter pylori in Mongolian gerbils. ( Arakawa, T; Fujiwara, Y; Hamaguchi, M; Higuchi, K; Matsumoto, T; Oshitani, N; Sasaki, E; Shiba, M; Takashima, T; Tanigawa, T; Tominaga, K; Watanabe, T, 2003) |
| "Among the 15 patients with hemorrhagic acute gastritis who were randomly allocated to group A (eradication therapy) or group B (Lansoprazole, LPZ), 10 of them started to receive treatment within 1 day after the disease onset." | 5.09 | A short-term eradication therapy for Helicobacter pylori acute gastritis. ( Asaka, M; Kashiwagi, S; Miyake, K; Nomura, H; Sugiyama, T, 2000) |
| " pylori-infected chronic gastritis by preventing the production of inflammatory cytokines and chemokines, as does cimetidine, but may be preferable to cimetidine for long-term administration for treatment of H." | 3.72 | Comparison of the effects of rebamipide with those of cimetidine on chronic gastritis associated with Helicobacter pylori in Mongolian gerbils. ( Arakawa, T; Fujiwara, Y; Hamaguchi, M; Higuchi, K; Matsumoto, T; Oshitani, N; Sasaki, E; Shiba, M; Takashima, T; Tanigawa, T; Tominaga, K; Watanabe, T, 2003) |
| "Chronic inflammation affecting the lesser curvature of the corpus was significantly improved in the rebamipide group compared to in the untreated group (1." | 2.80 | Rebamipide improves chronic inflammation in the lesser curvature of the corpus after Helicobacter pylori eradication: a multicenter study. ( Akiyama, T; Haruma, K; Hata, J; Inoue, K; Ito, M; Kamada, T; Manabe, N; Matsumoto, H; Murao, T; Sato, M; Shiotani, A; Tanaka, S; Tokutomi, T; Watanabe, T, 2015) |
| "Improvement of gastritis is expressed not only in quantity but also in quality of gastritis, which is shown as the reduction of iNOS expression in the gastric mucosa." | 2.42 | Review article: clinical significance of mucosal-protective agents: acid, inflammation, carcinogenesis and rebamipide. ( Haruma, K; Ito, M, 2003) |
| "pylori obtained from gastric cancer patients secreted Tip alpha in significantly higher amounts than did H." | 1.35 | TNF-alpha-inducing protein, a carcinogenic factor secreted from H. pylori, enters gastric cancer cells. ( Fujiki, H; Hayashi, T; Imai, K; Kuzuhara, T; Matsumoto, H; Nishizono, A; Ogawa, T; Ono, Y; Suganuma, M; Yamaguchi, K, 2008) |
| "Pretreatment with omeprazole (30 mg/kg s." | 1.30 | Influence of rebamipide on indometacin-induced gastric hemorrhage in rats under restraint stress. ( Arakawa, T; Higuchi, K; Kobayashi, K; Kuroki, T; Takaishi, O; Yamasaki, K, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 12 (57.14) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| He, Q | 1 |
| Liu, M | 1 |
| Rong, Z | 1 |
| Liang, H | 1 |
| Xu, X | 1 |
| Sun, S | 1 |
| Lei, Y | 1 |
| Li, P | 1 |
| Meng, H | 1 |
| Zheng, R | 1 |
| Bi, Y | 1 |
| Chen, X | 2 |
| Wang, B | 2 |
| Zhao, J | 1 |
| Jiang, K | 2 |
| Kim, GH | 1 |
| Lee, HL | 1 |
| Joo, MK | 1 |
| Park, HJ | 1 |
| Jung, SW | 1 |
| Lee, OJ | 1 |
| Kim, H | 1 |
| Chun, HJ | 1 |
| Lee, ST | 1 |
| Kim, JW | 1 |
| Jeon, HH | 1 |
| Chung, IK | 1 |
| Kim, HS | 1 |
| Lee, DH | 1 |
| Kim, KO | 1 |
| Lim, YJ | 1 |
| Park, SJ | 1 |
| Cho, SJ | 1 |
| Kim, BW | 1 |
| Ko, KH | 1 |
| Jeon, SW | 1 |
| Kim, JG | 1 |
| Sung, IK | 1 |
| Kim, TN | 1 |
| Sung, JK | 1 |
| Park, JJ | 1 |
| Nishizawa, T | 1 |
| Nishizawa, Y | 1 |
| Yahagi, N | 1 |
| Kanai, T | 1 |
| Takahashi, M | 1 |
| Suzuki, H | 1 |
| Kamada, T | 1 |
| Sato, M | 1 |
| Tokutomi, T | 1 |
| Watanabe, T | 2 |
| Murao, T | 1 |
| Matsumoto, H | 2 |
| Manabe, N | 2 |
| Ito, M | 3 |
| Tanaka, S | 2 |
| Inoue, K | 1 |
| Shiotani, A | 1 |
| Akiyama, T | 1 |
| Hata, J | 1 |
| Haruma, K | 3 |
| Han, X | 1 |
| Zhou, L | 1 |
| Li, S | 1 |
| Naito, Y | 2 |
| Yoshikawa, T | 3 |
| Jung, K | 1 |
| Chin, YW | 1 |
| Chung, YH | 1 |
| Park, YH | 1 |
| Yoo, H | 1 |
| Min, DS | 1 |
| Lee, B | 1 |
| Kim, J | 1 |
| Genta, RM | 1 |
| Higuchi, K | 2 |
| Tanigawa, T | 1 |
| Hamaguchi, M | 1 |
| Takashima, T | 1 |
| Sasaki, E | 1 |
| Shiba, M | 1 |
| Tominaga, K | 1 |
| Fujiwara, Y | 1 |
| Oshitani, N | 1 |
| Matsumoto, T | 1 |
| Arakawa, T | 3 |
| Hahm, KB | 2 |
| Kim, DH | 1 |
| Lee, KM | 1 |
| Lee, JS | 1 |
| Surh, YJ | 1 |
| Kim, YB | 1 |
| Yoo, BM | 1 |
| Kim, JH | 1 |
| Joo, HJ | 1 |
| Cho, YK | 1 |
| Nam, KT | 1 |
| Cho, SW | 1 |
| Fujioka, T | 1 |
| Shimoyama, T | 1 |
| Itoh, M | 1 |
| Asaka, M | 2 |
| Ishii, H | 1 |
| Kuwayama, H | 1 |
| Sato, R | 1 |
| Kawai, S | 1 |
| Takemoto, T | 1 |
| Kobayashi, K | 2 |
| Matysiak-Budnik, T | 1 |
| van Niel, G | 1 |
| Mégraud, F | 1 |
| Mayo, K | 1 |
| Bevilacqua, C | 1 |
| Gaboriau-Routhiau, V | 1 |
| Moreau, MC | 1 |
| Heyman, M | 1 |
| Park, S | 1 |
| Oh, TY | 1 |
| Jin, JH | 1 |
| Choue, R | 1 |
| Du, Y | 1 |
| Li, Z | 1 |
| Zhan, X | 1 |
| Chen, J | 1 |
| Gao, J | 1 |
| Gong, Y | 1 |
| Ren, J | 1 |
| He, L | 1 |
| Zhang, Z | 1 |
| Guo, X | 1 |
| Wu, J | 1 |
| Tian, Z | 1 |
| Shi, R | 1 |
| Jiang, B | 1 |
| Fang, D | 1 |
| Li, Y | 1 |
| Suganuma, M | 1 |
| Yamaguchi, K | 1 |
| Ono, Y | 1 |
| Hayashi, T | 1 |
| Ogawa, T | 1 |
| Imai, K | 1 |
| Kuzuhara, T | 1 |
| Nishizono, A | 1 |
| Fujiki, H | 1 |
| Chitapanarux, T | 1 |
| Praisontarangkul, OA | 1 |
| Lertprasertsuke, N | 1 |
| Iinuma, S | 1 |
| Miyazaki, R | 1 |
| Yagi, N | 1 |
| Yoshida, N | 1 |
| Osumi, T | 1 |
| Hirao, Y | 1 |
| Kondo, M | 1 |
| Yamasaki, K | 1 |
| Takaishi, O | 1 |
| Kuroki, T | 1 |
| Nomura, H | 1 |
| Miyake, K | 1 |
| Kashiwagi, S | 1 |
| Sugiyama, T | 1 |
| Kido, S | 1 |
| Kitadai, Y | 1 |
| Sumii, M | 1 |
| Yoshihara, M | 1 |
| Chayama, K | 1 |
3 reviews available for alanine and Gastritis
| Article | Year |
|---|---|
Effect of supplementation with rebamipide for Helicobacter pylori eradication therapy: a systematic review and meta-analysis.
Topics: Alanine; Amoxicillin; Databases, Bibliographic; Drug Therapy, Combination; Gastritis; Helicobacter I | 2014 |
Review article: the role of rebamipide in the management of inflammatory disease of the gastrointestinal tract.
Topics: Alanine; Anti-Ulcer Agents; Cells, Cultured; Clinical Trials as Topic; Colitis; Gastritis; Helicobac | 2003 |
Review article: clinical significance of mucosal-protective agents: acid, inflammation, carcinogenesis and rebamipide.
Topics: Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Anticarcinogenic Agents; Gastri | 2003 |
9 trials available for alanine and Gastritis
| Article | Year |
|---|---|
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study.
Topics: Alanine; Double-Blind Method; Gastritis; Humans; Quinolones; Stomach Ulcer; Treatment Outcome | 2021 |
Rebamipide improves chronic inflammation in the lesser curvature of the corpus after Helicobacter pylori eradication: a multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Female; Gastritis; Helicobacter Infections; Helicobacter py | 2015 |
Effect of Rebamipide on the Premalignant Progression of Chronic Gastritis: A Randomized Controlled Study.
Topics: Alanine; CDX2 Transcription Factor; Disease Progression; Female; Gastric Mucosa; Gastritis; Helicoba | 2015 |
Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trial.
Topics: Adult; Aged; Alanine; Anti-Ulcer Agents; Double-Blind Method; Female; Gastric Mucosa; Gastritis; Hel | 2003 |
Anti-inflammatory effects of rebamipide according to Helicobacter pylori status in patients with chronic erosive gastritis: a randomized sucralfate-controlled multicenter trial in China-STARS study.
Topics: Adult; Alanine; Anti-Inflammatory Agents; Anti-Ulcer Agents; China; Dinoprostone; Female; Gastric Mu | 2008 |
An open-labeled study of rebamipide treatment in chronic gastritis patients with dyspeptic symptoms refractory to proton pump inhibitors.
Topics: Adult; Alanine; Anti-Ulcer Agents; Chronic Disease; Dyspepsia; Endoscopy, Gastrointestinal; Endpoint | 2008 |
Local gastric and serum concentrations of rebamipide following oral administration to patients with chronic gastritis.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Ch | 1996 |
A short-term eradication therapy for Helicobacter pylori acute gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Alanine; Amoxicillin; Ant | 2000 |
Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis.
Topics: Alanine; Anti-Ulcer Agents; Drug Administration Schedule; Gastrins; Gastritis; Helicobacter Infectio | 2002 |
9 other studies available for alanine and Gastritis
| Article | Year |
|---|---|
Rebamipide attenuates alcohol-induced gastric epithelial cell injury by inhibiting endoplasmic reticulum stress and activating autophagy-related proteins.
Topics: Alanine; Animals; Anti-Ulcer Agents; Autophagy-Related Proteins; Endoplasmic Reticulum Stress; Epith | 2022 |
Rebamipide: a gastrointestinal protective drug with pleiotropic activities.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Alendronate; Allopurinol; Animals; Anti-Inflammatory Agents | 2010 |
Anti-gastritis and wound healing effects of Momordicae Semen extract and its active component.
Topics: Alanine; Animals; Anti-Ulcer Agents; Calcitonin Gene-Related Peptide; Gastric Mucosa; Gastritis; Hel | 2013 |
Comparison of the effects of rebamipide with those of cimetidine on chronic gastritis associated with Helicobacter pylori in Mongolian gerbils.
Topics: Alanine; Animals; Anti-Ulcer Agents; Chemokines; Cimetidine; Gastrins; Gastritis; Gerbillinae; Helic | 2003 |
Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice.
Topics: Alanine; Animals; Anti-Ulcer Agents; Apoptosis; Blotting, Western; Cytokines; Gastric Mucosa; Gastri | 2003 |
Gastric Helicobacter infection inhibits development of oral tolerance to food antigens in mice.
Topics: Administration, Oral; Alanine; Anaphylaxis; Animals; Antigen Presentation; Antigens; Chickens; Femal | 2003 |
Preventive effect of the flavonoid, wogonin, against ethanol-induced gastric mucosal damage in rats.
Topics: Alanine; Animals; Anti-Ulcer Agents; Apoptosis; Arachidonic Acid; Cyclooxygenase 2; Cytoprotection; | 2004 |
TNF-alpha-inducing protein, a carcinogenic factor secreted from H. pylori, enters gastric cancer cells.
Topics: Alanine; Animals; Bacterial Proteins; Biomarkers, Tumor; Blotting, Western; Carcinogens; Chronic Dis | 2008 |
Influence of rebamipide on indometacin-induced gastric hemorrhage in rats under restraint stress.
Topics: Acute Disease; Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Catalas | 1999 |